Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report
暂无分享,去创建一个
E. Lonn | K. Swedberg | H. Schunkert | L. Ruilope | C. Johnston | T. Lüscher | W. Remme | R. Ferrari | T. Rabelink | H. Drexler | C. Pepine | Jerome D. Cohen | L. Hansson | D. Celermajer | D. Vaughan | J. Deanfield | B. Hornig | B. Dahlöf | V. Dzau | W. V. van Gilst | K. Bernstein | M. Ruzicka | T. Unger | A. Husain | A. Mimran | J. Mancini | H. Lazar | J. Díez | Michael Weber | B. Dahlöf | J. Dı́ez
[1] R. Dinsmore,et al. The QUinapril Ischemic Event Trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention , 1993, Cardiovascular Drugs and Therapy.
[2] Abu T. M. Serajuddin,et al. Relative Lipophilicities and Structural-Pharmacological Considerations of Various Angiotensin-Converting Enzyme (ACE) Inhibitors , 1992, Pharmaceutical Research.
[3] E. Lonn,et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. , 2001, The American journal of cardiology.
[4] F. Lallemand,et al. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin. , 2000, Circulation.
[5] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[6] H. Haber,et al. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) , 2000, Journal of the American College of Cardiology.
[7] D. Koehl,et al. Ramiprilat prevents the development of acute coronary endothelial dysfunction in the dog , 1999, Basic Research in Cardiology.
[8] L. Køber,et al. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute m yocardial infarction , 1999, The Lancet.
[9] U. Ikeda,et al. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. , 1999, The American journal of cardiology.
[10] A. Zeiher,et al. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options , 1999, Journal of internal medicine.
[11] L. Niskanen,et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.
[12] H. Drexler,et al. Endothelial dysfunction in human disease. , 1999, Journal of molecular and cellular cardiology.
[13] L. Køber,et al. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. , 1999, Lancet.
[14] R. Dinsmore,et al. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial. , 1999, The American journal of cardiology.
[15] I. Nishio,et al. [Angiotensin I converting enzyme]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.
[16] H. Drexler,et al. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.
[17] D. Vaughan,et al. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. , 1998, Hypertension.
[18] R. Schrier,et al. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial. , 1998, The American journal of cardiology.
[19] J. Morrow,et al. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. , 1998, The New England journal of medicine.
[20] R. Virmani,et al. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. , 1998, The Journal of clinical investigation.
[21] I Maruyama,et al. Biology of endothelium , 1998, Lupus.
[22] J. Ménard,et al. Local angiotensin II generation in the rat heart: role of renin uptake. , 1998, Circulation research.
[23] K. Bernstein. The role of tissue angiotensin-converting enzyme (ACE): studies of ACE mutant mice. , 1998, The American journal of cardiology.
[24] H. Crijns,et al. Functional effects of ACE-inhibitors on angiotensin I conversion in human vasculature , 1998 .
[25] P. Anversa,et al. Apoptosis and myocardial infarction , 1998, Basic Research in Cardiology.
[26] G. Berkenboom,et al. Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism. , 1997, Hypertension.
[27] M. Ruzicka,et al. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy. , 1997, The American journal of physiology.
[28] M. Pfeffer,et al. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators. , 1997, Circulation.
[29] J. Zhuo,et al. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. , 1997, Circulation.
[30] K. Weber,et al. Cultured myofibroblasts generate angiotensin peptides de novo. , 1997, Journal of molecular and cellular cardiology.
[31] P. Kovanen,et al. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. , 1997, Circulation.
[32] H. Drexler,et al. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. , 1997, Circulation.
[33] C. Bauters,et al. ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors following arterial injury. , 1997, Biochemical and biophysical research communications.
[34] T. Coffman,et al. Angiotensin‐II receptors: new targets for antihypertensive therapy , 1997, Clinical cardiology.
[35] A. Danser,et al. Is there an internal cardiac renin-angiotensin system? , 1996, Heart.
[36] E. Miyamoto,et al. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. , 1996, Circulation.
[37] K. Lindpaintner,et al. Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Harrison,et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.
[39] G. B. John Mancini,et al. Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .
[40] T. Lüscher,et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.
[41] M. Ruzicka,et al. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats. , 1995, Circulation.
[42] F. Pieruzzi,et al. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. , 1995, Circulation.
[43] L. Ruilope,et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. , 1995, Nephron.
[44] T. Maniatis,et al. Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .
[45] D. Zeeuw,et al. Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] D. Vaughan,et al. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. , 1995, The Journal of clinical investigation.
[47] B. Berk,et al. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. , 1995, Hypertension.
[48] H. Schunkert,et al. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. , 1995, Hypertension.
[49] R. Bohle,et al. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. , 1995, Hypertension.
[50] M. Ruzicka,et al. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. , 1995, Circulation.
[51] O. Hess,et al. Intracardiac Angiotensin‐Converting Enzyme Inhibition Improves Diastolic Function in Patients With Left Ventricular Hypertrophy due to Aortic Stenosis , 1994, Circulation.
[52] B. Swynghedauw,et al. Activation of Angiotensinogen and Angiotensin‐Converting Enzyme Gene Expression in the Left Ventricle of Senescent Rats , 1994, Circulation.
[53] H. Schunkert,et al. Angiotensin‐Converting Enzyme Inhibition Prolongs Survival and Modifies the Transition to Heart Failure in Rats With Pressure Overload Hypertrophy Due to Ascending Aortic Stenosis , 1994, Circulation.
[54] C. Johnston,et al. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme. , 1994, European journal of pharmacology.
[55] T. Unger,et al. Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. , 1994, Cardiovascular research.
[56] C. Johnston. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. , 1994, Hypertension.
[57] A Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[58] J. Sadoshima,et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro , 1993, Cell.
[59] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[60] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[61] Therapy Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.
[62] R. Alexander,et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. , 1993, The Journal of clinical investigation.
[63] C. Johnston,et al. The cardiac renin-angiotensin system in heart failure. , 1993, American heart journal.
[64] G. Hasenfuss,et al. Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. , 1993, Circulation.
[65] H. Urata,et al. Measurement of angiotensin I converting enzyme inhibition in the heart. , 1993, Circulation research.
[66] H. Schunkert,et al. Distribution and Functional Significance of Cardiac Angiotensin Converting Enzyme in Hypertrophied Rat Hearts , 1993, Circulation.
[67] B. Kasiske,et al. Effect of Antihypertensive Therapy on the Kidney in Patients with Diabetes: A Meta-Regression Analysis , 1993, Annals of Internal Medicine.
[68] S. Chaki,et al. Cloning, expression and regulation of angiotensin II receptors. , 1994, Journal of hypertension.
[69] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[70] D. Nash. Comparative properties of angiotensin-converting enzyme inhibitors: relations with inhibition of tissue angiotensin-converting enzyme and potential clinical implications. , 1992, The American journal of cardiology.
[71] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[72] H. Schunkert,et al. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. , 1991, Circulation research.
[73] K. Weber,et al. Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.
[74] P. Timmermans,et al. Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. , 1991, Hypertension.
[75] C. Johnston,et al. Localization of angiotensin converting enzyme in rat heart. , 1991, Circulation research.
[76] K. Misono,et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. , 1990, The Journal of biological chemistry.
[77] H. Schunkert,et al. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. , 1990, The Journal of clinical investigation.
[78] K. Baker,et al. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. , 1990, The American journal of physiology.
[79] C. Johnston,et al. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats , 1990, British journal of pharmacology.
[80] C. Johnston,et al. INCREASED CARDIAC ANGIOTENSIN‐CONVERTING ENZYME IN RATS WITH CHRONIC HEART FAILURE , 1990, Clinical and experimental pharmacology & physiology.
[81] B. Healy,et al. Angiotensin II-forming pathways in normal and failing human hearts. , 1990, Circulation research.
[82] Bin Chen,et al. Inhibition of Angiotensin‐Converting Enzyme (ACE) in Plasma and Tissue , 1990, Journal of cardiovascular pharmacology.
[83] M. Peach,et al. The angiotensin II receptor and the actions of angiotensin II. , 1990, Journal of cardiovascular pharmacology.
[84] C. Johnston,et al. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[85] L. Ruilope,et al. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[86] G. Riegger,et al. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. , 1988, The American journal of cardiology.
[87] Skidgel Ra,et al. The angiotensin I-converting enzyme. , 1977 .
[88] H. Cheung,et al. Concentrations of angiotensin-converting enzyme in tissues of the rat. , 1971, Biochimica et biophysica acta.
[89] J. Vane,et al. Fate of Angiotensin I in the Circulation , 1968, Nature.
[90] J. Tomaszewski,et al. Renin and angiotensin. , 1968, Lancet.